๐ฐ Prescribing Patterns News
Prescribing Patterns News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Prescribing Patterns. Real-time updates on events, politics, business and more.
January 17, 2024
The Adderall shortage continues as a study reveals a spike in ADHD medication prescriptions during the pandemic, particularly among women and young adults.
January 3, 2024
However, comprehensive policy and payment structures are needed to ensure care sustainability.
August 7, 2023
/PRNewswire/ -- New research in the August 2023 issue of JNCCNโJournal of the National Comprehensive Cancer Network evaluates how an important analysis on...
August 7, 2023
JNCCN study sheds light on a rapid shift in practice evolution by oncologists treating people with colon cancer adjuvantly after primary surgery, following publications from the IDEA collaboration.
June 28, 2023
/PRNewswire/ -- The European Society of Hypertension (ESH), the leading hypertension society in Europe, released updated and expanded 2023 ESH Guidelines for...
March 22, 2023
Specific dosing regimens of treatments prescribed by blood specialists have not been widely studied, despite the advent of newer hemophilia therapies, the researchers said.
February 21, 2023
Objective: To examine patient characteristics, persistence and adherence to treatment associated with use of second-generation antipsychotic long-acting injectable (SGA LAI) medications in the Australian real-world setting. Method: Five SGA LAIs were compared using a retrospective 10% sample of prescriptions in Australian Pharmaceutical Benefits Scheme (PBS) data: paliperidone palmitate 1-monthly (PP1M), paliperidone palmitate 3-monthly (PP3M), aripiprazole monohydrate (ARI), risperidone (RLAI) ...
March 9, 2022
Background: To examine real-world patterns of antipsychotic use in patients with schizophrenia Australia. Methods: This retrospective cohort analysis was conducted using the Australian Commonwealth Department of Human Services Pharmaceutical Benefits Scheme (PBS) 10% sample data. Included data were for patients aged 16-years or older who initiated treatment for the first time with a PBS-reimbursed antipsychotic medication for schizophrenia between July 2013 and September 2017. Patterns of treatm...